Document is current
Any future updates will be listed below
-
Authors
Zhu, Qi https://orcid.org/0009-0006-7708-4064
Li, Jiajia
Liu, Nan
Han, Lu
Wu, Zhiqiang https://orcid.org/0000-0002-1971-9889
Wang, Yao https://orcid.org/0000-0002-9352-422X
Lin, Xin https://orcid.org/0000-0003-0956-3654
Wei, Jianshu
Han, Weidong https://orcid.org/0000-0003-3207-3899
-
Funding
Funding for this research was provided by:
National Science Foundation of China | Key Programme (82430012, 82341208)
- License Information
-
More Information
Article History
Received: 4 February 2025
Accepted: 18 June 2025
First Online: 4 July 2025
Competing interests
: JW, QZ, ZW, YW, XL and WH have submitted Chinese patent applications for the design and application of CD2-CAR-T cells. All other authors declare that they have no competing interests. No authors have participated in paid or unpaid consulting. WH and XL are editorial board members of Cellular & Molecular Immunology, but they have not been involved in the peer review or the decision-making of the article.
